Patents by Inventor Efrain Hernandez

Efrain Hernandez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OPEN-BORE CO-ELECTRODEPOSITION OF METAL MATRIX COMPOSITE COATINGS USING PERMANENT MAGNETS
    Publication number: 20220093302
    Abstract: An apparatus includes an electrochemical cell with an electrolyte solution containing particles and metal ions; an electrode system disposed in the electrolyte solution, wherein the electrode system includes a counter electrode, a reference electrode, and a working electrode, and wherein the counter electrode and the working electrode are arranged to allow electric current to flow therebetween; and an open-bore magnet arrangement having at least one permanent magnet connected to the electrochemical cell and arranged to produce a magnetic field in the electrolyte solution to interact with the electric current to produce an electrodeposition of the particles with metal derived from the metal ions onto the working electrode.
    Type: Application
    Filed: September 22, 2020
    Publication date: March 24, 2022
    Inventors: Heather A. Murdoch, Efrain Hernandez, Denise Yin
  • Use of adenosine aspartate for the preparation of pharmaceutical products for the treatment of liver cancer
    Patent number: 8507459
    Abstract: The present invention relates to the novel use of an adenosine aspartate product for the formulation of a drug intended to prevent the development of preneoplastic lesions and to reverse some types of cancer, particularly liver cancer, providing chemoprotection, preventing myelotoxic effects.
    Type: Grant
    Filed: August 21, 2008
    Date of Patent: August 13, 2013
    Assignee: Universidad Nacional Autonnoma de Mexico
    Inventors: Victoria-Eugenia Chagoya-Hazas, Rolando-Efraín Hernandez Muñoz, Saúl Villa-Treviño
  • USE OF ADENOSINE ASPARTATE FOR THE PREPARATION OF PHARMACEUTICAL PRODUCTS FOR THE TREATMENT OF LIVER CANCER
    Publication number: 20110105425
    Abstract: The present invention relates to the novel use of an adenosine aspartate product for the formulation of a drug intended to prevent the development of preneoplastic lesions and to reverse some types of cancer, particularly liver cancer, providing chemoprotection, preventing myelotoxic effects.
    Type: Application
    Filed: August 21, 2008
    Publication date: May 5, 2011
    Applicant: UNIVERSIDAD NACIONAL AUTONOMA DE MEXICO
    Inventors: Victoria-Eugenia Chagoya-Hazas, Rolando-Efrain Hernandez Muñoz, Saúl Villa-Treviño